Ciliary neurotrophic factor (Roche)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCiliary neurotrophic factor (Roche)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionCiliary neurotrophic factor replacements
TargetsCiliary neurotrophic factor receptor
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksWikipedia